Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Aging (Albany NY) ; 14(3): 1186-1199, 2022 02 08.
Article in English | MEDLINE | ID: mdl-35134749

ABSTRACT

BACKGROUND: Incidence of breast cancer (BC) in US women continues to increase with age as the strongest risk factor. We aimed to compare clinical, pathological and sociological variables associated to BC diagnosis, as well as the relative mortality rates of BC patients compared to the general US population. METHODS: We performed a retrospective, single-institution study evaluating 52,509 patients diagnosed with unilateral BC at the University of Pittsburgh Medical Center (UPMC) between 1990-2020. Primary outcome was death from any cause with cancer recurrence as a secondary outcome, evaluated for 4 age groups: 20-44, 45-55, 56-69, and 70-90. A dataset of expected mortality for women in the general population over a 10-year period was constructed using the Surveillance, Epidemiology, and End Results (SEER) Program. Observed vs. expected mortality and standardized mortality ratios (SMR) for each age group were calculated. RESULTS: Youngest patients with BC demonstrated the highest SMR at 10-year follow-up from time of diagnosis compared to the general US population (SMR 9.68, 95% CI: 8.99to 10.42), and remained highest compared to other age groups when analysis was limited to Stage 0/1 disease (10-year SMR 3.11, 95% CI: 2.54 to 3.76). SMRs decreased with increasing age at diagnosis with an SMR <1.0 in patients diagnosed with stage 0/1 at ages 70-90 at 5-year follow-up. CONCLUSIONS: Younger BC patients have the highest SMR which declines gradually with age. In the elderly, lower stage 0/1 SMR's are found compared to the general population, suggesting the possibility of an associated protective effect.


Subject(s)
Breast Neoplasms , Aged , Aged, 80 and over , Female , Humans , Incidence , Neoplasm Recurrence, Local , Retrospective Studies , Risk Factors
2.
Respir Res ; 22(1): 100, 2021 Apr 06.
Article in English | MEDLINE | ID: mdl-33823868

ABSTRACT

BACKGROUND: Whole lung tissue transcriptomic profiling studies in chronic obstructive pulmonary disease (COPD) have led to the identification of several genes associated with the severity of airflow limitation and/or the presence of emphysema, however, the cell types driving these gene expression signatures remain unidentified. METHODS: To determine cell specific transcriptomic changes in severe COPD, we conducted single-cell RNA sequencing (scRNA seq) on n = 29,961 cells from the peripheral lung parenchymal tissue of nonsmoking subjects without underlying lung disease (n = 3) and patients with severe COPD (n = 3). The cell type composition and cell specific gene expression signature was assessed. Gene set enrichment analysis (GSEA) was used to identify the specific cell types contributing to the previously reported transcriptomic signatures. RESULTS: T-distributed stochastic neighbor embedding and clustering of scRNA seq data revealed a total of 17 distinct populations. Among them, the populations with more differentially expressed genes in cases vs. controls (log fold change >|0.4| and FDR = 0.05) were: monocytes (n = 1499); macrophages (n = 868) and ciliated epithelial cells (n = 590), respectively. Using GSEA, we found that only ciliated and cytotoxic T cells manifested a trend towards enrichment of the previously reported 127 regional emphysema gene signatures (normalized enrichment score [NES] = 1.28 and = 1.33, FDR = 0.085 and = 0.092 respectively). Among the significantly altered genes present in ciliated epithelial cells of the COPD lungs, QKI and IGFBP5 protein levels were also found to be altered in the COPD lungs. CONCLUSIONS: scRNA seq is useful for identifying transcriptional changes and possibly individual protein levels that may contribute to the development of emphysema in a cell-type specific manner.


Subject(s)
Insulin-Like Growth Factor Binding Protein 5/genetics , Lung/metabolism , Pulmonary Disease, Chronic Obstructive/genetics , RNA-Binding Proteins/genetics , RNA/genetics , Sequence Analysis, RNA/methods , Transcriptome/genetics , Adult , Aged , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Gene Expression Profiling/methods , Humans , Insulin-Like Growth Factor Binding Protein 5/biosynthesis , Lung/pathology , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/metabolism , Pulmonary Disease, Chronic Obstructive/pathology , RNA/metabolism , RNA-Binding Proteins/biosynthesis , Severity of Illness Index , Young Adult
3.
Proc Am Thorac Soc ; 8(3): 215-22, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21653526

ABSTRACT

In April 2010, a NIH workshop was convened to discuss the current state of understanding of lung cell plasticity, including the responses of epithelial cells to injury, with the objectives of summarizing what is known, what the field needs to know, and how to get there. The proximal stimulus for this workshop is the body of recent evidence suggesting that plasticity is a prominent but incompletely characterized property of lung epithelial cells, and that a focus on understanding this aspect of epithelial cell biology in particular, may be an important window into disease pathobiology and pathogenesis. In addition to their many vital functions in maintaining tissue homeostasis, epithelial cells have emerged as both a central target of disease initiation and an active contributor to disease progression, making a workshop to investigate the role of cell plasticity in lung injury and repair timely. The workshop was organized around four major themes: lung epithelial cell plasticity, signaling control of plasticity, fibroblast plasticity and crosstalk, and translation to human disease. Although this breakdown was recognized to be somewhat artificial, it was felt that this approach would promote cross-fertilization among groups that ordinarily do not communicate and lend itself to the generation of new approaches. The summary reports of individual group discussions below are followed by consensus priorities and recommendations of the workshop participants.


Subject(s)
Epithelial Cells/pathology , Lung Diseases/pathology , Animals , Biomarkers , Cell Differentiation , Cell Lineage , Disease Models, Animal , Epigenesis, Genetic , Fibroblasts/physiology , Gene Expression Regulation , Genetic Markers , Humans , Lung/cytology , Lung/embryology , Lung Diseases/physiopathology , Microscopy , Neoplastic Stem Cells , Precision Medicine , Pulmonary Alveoli/cytology , Signal Transduction , Stem Cells/physiology , Wnt Proteins/metabolism
4.
Am J Respir Crit Care Med ; 176(8): 778-85, 2007 Oct 15.
Article in English | MEDLINE | ID: mdl-17673697

ABSTRACT

RATIONALE: Bronchopulmonary dysplasia (BPD) is a chronic lung disease that adversely affects long-term pulmonary function as well as neurodevelopmental outcomes of preterm infants. Elastolytic proteases have been implicated in the pathogenesis of BPD. Cathepsin S (cat S) is a cysteine protease with potent elastolytic activity. Increased levels and activity of cat S have been detected in a baboon model of BPD. OBJECTIVES: To investigate whether deficiency of cat S alters the course of hyperoxia-induced neonatal lung injury in mice. METHODS: Newborn wild-type and cat S-deficient mice were exposed to 80% oxygen for 14 days. Histologic and morphometric analysis were performed and bronchoalveolar lavage protein and cells were analyzed. Lung elastin was assessed by real-time polymerase chain reaction, in situ hybridization, desmosine analysis, and Hart's stain. Distribution of myofibroblasts was analyzed by immunofluorescence. Hydroxyproline content of lung tissues was measured. MEASUREMENTS AND MAIN RESULTS: Hyperoxia-exposed cat S-deficient mice were protected from growth restriction and had improved alveolarization, decreased septal wall thickness, lower number of macrophages, and lower protein concentration in bronchoalveolar lavage fluid. alpha-Smooth muscle actin-expressing myofibroblasts accounted for at least some of the increased interstitial cellularity in hyperoxia-exposed mouse lungs and were significantly less in cat S-deficient lungs. Lung hydroxyproline content was increased in hyperoxia-exposed wild-type, but not in cat S-deficient lungs. Desmosine content was significantly reduced in both genotypes with hyperoxia. CONCLUSIONS: Cathepsin S deficiency improves alveolarization, and attenuates macrophage influx and fibroproliferative changes in hyperoxia-induced neonatal mouse lung injury.


Subject(s)
Bronchopulmonary Dysplasia/metabolism , Cathepsins/deficiency , Hyperoxia/complications , Lung/metabolism , Animals , Animals, Newborn , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Cathepsins/metabolism , Collagen/metabolism , Desmosine/metabolism , Disease Models, Animal , Elastin/metabolism , Humans , Hydroxyproline/metabolism , Hyperoxia/metabolism , Infant, Newborn , Lung/pathology , Lung Injury , Macrophages, Alveolar/metabolism , Mice , Proteins/metabolism , Pulmonary Alveoli/growth & development , RNA, Messenger/metabolism
6.
Int Immunopharmacol ; 5(3): 511-24, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15683848

ABSTRACT

Macrophage elastase (MMP-12) is a metalloproteinase able to degrade extracellular matrix components such as elastin. As many MMPs, MMP-12 is involved in acute and chronic lung injury. However, its role in the inflammatory process of the lung parenchyma is not clearly understood. In this study, we have investigated the effects of airway instillation of rhMMP-12 on inflammatory cell recruitment, cytokine release and gelatinase expression in bronchoalveolar lavage fluid (BALF) or in lung homogenate supernatants in mice. Numbers of total and individual cell types were examined in BALF during the first 72 h following rhMMP-12 instillation. A marked recruitment of neutrophils was observed with a maximum increase at 18 h. This cellular recruitment was associated with a very transient increase in IL-6, TNF-alpha MIP-1alpha, MCP-1 and KC levels and gelatinase expression in BALF and in lung homogenate supernatants. From days 4 to 15, performing the same analyses, we observed an important and stable recruitment of macrophages in BALF in absence of the other studied inflammatory markers. These results demonstrate that rhMMP-12 itself is able to induce an early inflammatory response characterized by neutrophil infiltration, cytokine release and gelatinase activation followed by a later response composed mainly of macrophage recruitment.


Subject(s)
Catalytic Domain , Inflammation/metabolism , Lung/drug effects , Metalloendopeptidases/pharmacology , Recombinant Proteins/pharmacology , Administration, Inhalation , Animals , Bronchoalveolar Lavage Fluid/cytology , Cell Count , Chemokines/metabolism , Cytokines/metabolism , Enzyme Precursors/metabolism , Humans , Inflammation/chemically induced , Lung/metabolism , Lung/pathology , Macrophages, Alveolar/cytology , Matrix Metalloproteinase 12 , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Metalloendopeptidases/genetics , Mice , Mice, Inbred A , Mice, Inbred C57BL , Mice, Knockout , Neutrophils/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...